NEURONIX
Yoqne`am `illit
About NEURONIX
Neuronix’s mission is to turn Dementia a Manageable Chronic Disease, by introducing new methods for modifying the course of treatment for Neuro-degenerative Diseases and in particular Alzheimer Disease (AD). Thus, offering hope and long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by an Advisory Board made up of key opinion leaders in the field, Neuronix’s neuroAD technology is currently undergoing advanced clinical trials in major medical centers across the globe.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.5M
- Last round: Series Unknown (Feb 2014)
- Website: neuronixmedical.com
- Phone: +972 4-983-1938
Industries & Categories
Clinical Trials, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/neuronix-2799909 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.